Streetbeat News

Price Targets

LRCX

Stifel analyst Brian Chin has maintained a Buy rating on Lam Research (NASDAQ:LRCX) and increased the price target from $850 to $950. The report was released on January 24, 2024.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:58 pm

LRN

BMO Capital analyst Jeffrey Silber has reaffirmed an Outperform rating on Stride Inc. (NYSE:LRN) and increased the price target from $71 to $72, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:58 pm

TSLA

Barclays analyst Dan Levy has maintained an Equal-Weight rating on Tesla (NASDAQ:TSLA) but has reduced the price target from $250 to $225.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:57 pm

SWTX

Barclays analyst Peter Lawson has maintained an Overweight rating on SpringWorks Therapeutics (NASDAQ:SWTX) and increased the price target from $41 to $47, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:56 pm

K

Stifel analyst Matthew Smith has maintained a Hold rating on Kellanova (NYSE:K) and increased the price target from $56 to $58.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:56 pm

SHC

Barclays analyst Luke Sergott has maintained an Overweight rating on Sotera Health (NASDAQ:SHC) and increased the price target from $15 to $17.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:56 pm

SJM

Stifel analyst Matthew Smith has maintained a Hold rating on JM Smucker (NYSE:SJM) and increased the price target from $125 to $135. This adjustment reflects a positive view on the company's future performance, suggesting that the stock may have some upside potential, but not enough to warrant a Buy rating at this time.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:55 pm

RVTY

Barclays analyst Luke Sergott has maintained an Equal-Weight rating on Revvity (NYSE:RVTY) and increased the price target from $92 to $105.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:54 pm

IBM

Stifel analyst David Grossman has maintained a Buy rating on IBM and increased the price target from $183 to $190.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:53 pm

PG

Barclays analyst Lauren Lieberman has maintained an Overweight rating on Procter & Gamble (NYSE:PG) and increased the price target from $160 to $165.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 2:53 pm